The Novel Tumor Angiogenic Factor, Adrenomedullin-2 (ADM2) Predicts Survival in Pancreatic Adenocarcinoma
Hollander L, Guo X, Salem R, Cha C. The Novel Tumor Angiogenic Factor, Adrenomedullin-2 (ADM2) Predicts Survival in Pancreatic Adenocarcinoma. Journal Of Surgical Research 2014, 186: 635-636. DOI: 10.1016/j.jss.2013.11.651.Peer-Reviewed Original ResearchAdrenomedullin 2Pancreatic adenocarcinoma